legal-news
7:24-cv-08751 Regeneron Pharmaceuticals, Inc. v. Sanofi Biotechnology SAS et al
24-cv-08751
|
|
Filed
Active
Sign in to follow this case
Advertisement
description
Case Summary
In the case 7:24-cv-08751 Regeneron Pharmaceuticals, Inc. v. Sanofi Biotechnology SAS et al, Regeneron Pharmaceuticals has initiated litigation against Sanofi Biotechnology and related parties. The dispute likely involves complex issues related to biotechnology, potentially including patent rights, licensing agreements, or competitive practices within the pharmaceutical industry. The docket includes a letter filed in the case, indicating ongoing procedural or substantive communications between the parties or with the court. Specific details about the claims or defenses are not provided in the available information.
Key Issues
- • Intellectual property rights in biotechnology
- • Patent infringement or validity
- • Licensing agreements and contractual obligations
- • Competitive practices in the pharmaceutical industry
- • Procedural motions and court communications
Advertisement
Case Timeline
1 event
info
Other
April 14, 2026
7:24-cv-08751 Regeneron Pharmaceuticals, Inc. v. Sanofi Biotechnology SAS et al
[Letter] (<a href="https://ecf.nysd.uscourts.gov/doc1/127139422231?caseid=631879&de_seq_num=215">70</a>)
Advertisement
newspaper
1 article